Unusual Options Activity Insight: AstraZeneca
Shares of AstraZeneca (NASDAQ:AZN) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved up to $58.16.
‘CDC officials hold meeting to discuss Covid-19 vaccine booster shots’ -CNBC Television
https://www.youtube.com/watch?v=MA7eG_p0EZc
Moderna’s Shot Seems To Have A Better Shot Against Delta Than Pfizer’s
Besides proudly stating that its Covid-19 shot produced a "robust" antibody response against the highly contagious delta variant last Thursday, Moderna (NASDAQ: MRNA) also posted second-quarter financial results that beat Wall Street's expectations on both earnings and revenue.
Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links
The European Medicines Agency is investing a possible link between mRNA vaccines and erythema multiforme or two kidney disorders by…
Facebook Blocks Russia Based Ad Agency Behind COVID-19 Vaccine Smear Campaign
Facebook Inc (NASDAQ:FB) removed multiple accounts linked to a mysterious advertising agency operating out of Russia that sought to…
Unusual Options Activity Insight: AstraZeneca
On Thursday, shares of AstraZeneca (NASDAQ:AZN) saw unusual options activity. After the option alert, the stock price moved up to $57.2.
Britain Study Shows Restricted Use Of AstraZeneca COVID-19 Shot Associated With No Clot Cases: Reuters
Following a decision to restrict the use of University of Oxford / AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine in those under the age of 40 years, no new cases of blood clots were found in Britain in recent weeks after receiving the jab, a study has found.